ACTIVE

THERAPY BY MS

Financial year 2025 · closed on 31/12/2025
Net result
-13,1 k €
-548.1% YoY
Gross margin
-8,3 k €
-161.6% YoY
Equity
-12,6 k €
-2486.9% YoY

What does THERAPY BY MS do?

THERAPY BY MS is a Private limited company incorporated in 2023. Its main activity is: Other human health activities. Its registered office is in Bruxelles.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0799.085.307
Incorporation
02/03/2023
Legal form
Private limited company
Registered office
Rue François Vekemans 151
1120 Bruxelles · BruxellesSee on map
Contributed capital
1 000,00 €
Latest accounts
31/12/2025
Contacts
1 public detail availableLog in to view
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202520242023
Income statement
Gross margin-8,3 k €13,5 k €32,2 €
EBITDA-11,7 k €5,1 k €-2 k €
Operating result-13 k €4,5 k €-3,4 k €
Net result-13,1 k €2,9 k €-3,4 k €
Balance sheet
Equity-12,6 k €527,4 €-2,4 k €
Total assets10,1 k €15 k €10,3 k €
Cash5,9 k €13,4 k €8,9 k €
Debts22,7 k €14,5 k €12,7 k €
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active

Active mandates

SARA MOUADINE

Director · since 27 février 2023

Active
At this address

Other companies at this address

CompanyCBE no.
0838.162.449
BETTIMEDActive
0800.186.355
0780.977.979
KR-MEDICALActive
1004.407.581
Annual accounts

Full financial information

202520242023
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202402/03/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months10 months
Filing date20/07/202625/07/202530/07/2024
General meeting30/06/202624/06/202525/06/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202530/06/202620/07/2026FrenchPDF
Micro model31/12/202424/06/202525/07/2025FrenchPDF
Micro model31/12/202325/06/202430/07/2024FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active

Active mandates

SARA MOUADINE

Director · since 27 février 2023

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates19/02/2026
    DIVERS - DEMISSIONS, NOMINATIONS
    PDF
  • Other06/03/2023
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-13,1 k €
  2. 2024
    Annual accounts 20242,9 k €
  3. 2023
    Annual accounts 2023-3,4 k €
  4. 02/03/2023
    IncorporationPrivate limited company